GSK claims victory in first round of battle over anti-depressant patents.
Publication: Europe Intelligence Wire
Publication Date: 31-DEC-02
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
DRUGS firm GlaxoSmithKline claimed a partial victory in its battle to prevent the launch of generic competition to its key Paxil treatment.
The pharmaceutical company said there were still "significant hurdles" facing its rivals despite a US judge dismissing one patent related to the anti-depressant....
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
